Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx

References

• Breitbart WS, Holland JC. 1989. Head and neck cancer. In Holland JC, Rowland JH, editors. Handbook of psycho-oncology: psychological care of the patient with cancer. New York: Oxford University Press. p 232–9.
   Google Scholar
• Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876–83.
   PubMed Web of Science ®Google Scholar
• Lefebvre J-L. Current clinical outcomes demand new treatment options for SCCHN. Ann Oncol 2005;16:vi7–vi12.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Bourthis J, Domenge C, Desibné L; On behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949–55.
   PubMed Web of Science ®Google Scholar
• Japan Society for Head and Neck Cancer. editors. 2009;Clinical Practice Guideline for Head and Neck Cancer. Tokyo: Kanehara & Co. Ltd. p 25–30; in Japanese.
   Google Scholar
• National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
   Google Scholar
• National Cancer Institute. http:/www.cancer.gov/cancertopics/pdq/cancerdatabase.
   Google Scholar
• Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24:3693–704.
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695–704.
   PubMed Web of Science ®Google Scholar
• Postner MR, Hershock DM, Blajiman CR, Mackiewitz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705–15.
   PubMed Web of Science ®Google Scholar
• Paccagnella A, Orland A, Marchiori C, Zorat PL, Cavaniglia G, Sileni VC, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994;86:265–72.
   PubMed Web of Science ®Google Scholar
• Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1997;324:1685–90.
   Google Scholar
• Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091–8.
   PubMed Web of Science ®Google Scholar
• Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998;34:224–8.
   PubMed Web of Science ®Google Scholar
• Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009;119:1312–17.
   PubMed Web of Science ®Google Scholar
• Furusaka T, Matsuda H, Saito T, Katsura Y, Ikeda M. Long term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone. Acta Otolaryngol 2012;132:546–51.
   PubMed Web of Science ®Google Scholar
• Staton J, Robbins KT, Newman L, Samant S, Sebelik M, Vieira F. Factors predictive of poor functional outcome after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg 2002;127:43–7.
   PubMed Web of Science ®Google Scholar
• Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364–71.
   PubMed Web of Science ®Google Scholar
• Rasch CR, Haupmann M, Schornagel J, Wijers O, Buter J, Gregor T, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 2010;98:2159–65.
   Google Scholar
• Furusaka T, Asakawa T, Tanaka A, Matsuda M, Ikeda M. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta Otolaryngol 2012;132:1108–14.
   PubMed Web of Science ®Google Scholar